Eculizumab: Solution concentrate for I.V. infusion 300 mg in 30 mL; Soliris® Page last updated: 4 March 2022 Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 1339KB) Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 208KB)